glp-1 drugs thyroid cancer Do GLP-1ra increase the risk of cancer? ➡️There was once a concern about a very rare type, called “medullary thyroid cancer,” due to rodent studies and their receptors on those GLP-1s in Oncology: Exploring Risks

L-carnitine is an amino acid that constitutes an essential cofactor in the metabolism of fatty acids, acting in the reduction of triglycerides and cholesterol, increasing lipid oxidation and the delivery of long-chain free fatty acids for mitochondrial oxidation [5,8]

N Engl J Med 385(6):503515

Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors

Consult a qualified nutritionist for their expert guidance on whether L-carnitine either in supplement or food-based form is something to have on your priority list